1. Home
  2. VPG vs VNDA Comparison

VPG vs VNDA Comparison

Compare VPG & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VPG

Vishay Precision Group Inc.

HOLD

Current Price

$44.78

Market Cap

552.5M

Sector

Technology

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$6.95

Market Cap

474.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VPG
VNDA
Founded
2009
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
552.5M
474.0M
IPO Year
2010
2005

Fundamental Metrics

Financial Performance
Metric
VPG
VNDA
Price
$44.78
$6.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$53.50
$14.90
AVG Volume (30 Days)
209.6K
1.6M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.40
N/A
Revenue
$307,202,000.00
$216,105,000.00
Revenue This Year
$7.21
$21.35
Revenue Next Year
$6.92
$37.40
P/E Ratio
$111.93
N/A
Revenue Growth
0.22
8.72
52 Week Low
$18.57
$3.81
52 Week High
$56.25
$9.91

Technical Indicators

Market Signals
Indicator
VPG
VNDA
Relative Strength Index (RSI) 52.95 42.47
Support Level $44.01 $4.39
Resistance Level $48.61 $8.29
Average True Range (ATR) 2.64 0.44
MACD 0.36 -0.14
Stochastic Oscillator 67.19 16.93

Price Performance

Historical Comparison
VPG
VNDA

About VPG Vishay Precision Group Inc.

Vishay Precision Group Inc manufactures and markets sensors and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: